As growing numbers of people live well into their 80s and 90s, age-related diseases and conditions, and the disability often associated with them, have become a massive public health concern. Academic research is attentive to the call, and is utilizing cutting-edge science and new paradigms of thinking in an attempt to combat age-related illnesses and [...]
by Carly Helfand | May 8, 2017 10:50am Adherence tech company Medisafe offers an intelligent feed feature as part of its interface that can function as a content publishing platform for pharma partners. Drugmakers are offering more support programs for patients taking their meds, but patients don’t always know about them. Imagine if pharma could [...]
AN OPPORTUNITY NOT TO BE MISSED – TAKE AN ACTIVE ROLE This is your last chance to take advantage of our Early Bird Registration rates which ends on Monday, May 8th. Dear Colleagues, We welcome you to register for the full 3 day Conference and Exhibition to fully experience the Biomed Industry, or register for daily participation to [...]
*************** הכנס שיגיעו אליו אלפי משקיעים מהעולם - ואף לא מוסדי ישראלי כנס MIXII BIOMED הוא אחד הכנסים החשובים והמובילים בעולם בתחום מדעי החיים, שיוצגו בו טכנולוגיות עלית ישראליות בתחומים פורצי דרך - אבל את המוסדיים הישראליים זה כנראה לא מעניין 25/04/2017 בחודש מאי השנה ייערך בישראל כנס MIXII BIOMED ה-16 של ארגון הגג של [...]
by Carly Helfand | Apr 17, 2017 Treato CEO Ido Hadari says patient centricity has become "a pillar in every life sciences and healthcare company out there." YEHUD, ISRAEL—Compare pharma's ideas about patient centricity today with their ideas a few years back, and “it would probably be like landing on different planets,” according to Ido [...]
Israeli firm MeMed won a contract worth up to $9.2 million from the U.S. Department of Defense (DoD) Defense Threat Reduction Agency (DTRA) to complete the development of a point-of-care in vitro diagnostic platform that can distinguish between bacterial and viral infections, and so help to prevent antibiotic misuse. MeMed’s diagnostic platform uses infection-specific immune [...]
AN OPPORTUNITY NOT TO BE MISSED – TAKE AN ACTIVE ROLE REGISTER NOW (Early Bird Registration Deadline May 08, 2017) Dear Colleagues, Mixiii Biomed 2017 is generating great interest, with registration at its height. Ensure that you take advantage of the Early Bird Registration Fee (until 12:00 midnight May 8) and Register Now! For the 16th [...]
Only 7 days left to register to MIXiii Biomed 2017 Start-up Area and Competition by: Israel Innovation Authority! For competition details please click here. Competition registration deadline: 10 APRIL 2017 REGISTER NOW Join the road to success and grab the chance to be an active participant at MIXiii BIOMED 2017! As a registered participant [...]
BiolineRx buys UK co Agalimmune 23 Mar, 2017 14:29 Gali Weinreb BiolineRx is paying $6 million upfront for Agalimmune, which has developed a new immunotherapy solution for treating cancer. BiolineRx Ltd. (Nasdaq: BLRX); TASE:BLRX) has announced the acquisition of Agalimmune Ltd., a private UK-based company with an innovative, anti-cancer immunotherapy platform. BiolineRx is paying [...]
Цифровая медицина: новые изобретения израильтян Производство электронных медицинских приборов стало одной из перспективных отраслей израильского хай-тека. В 2016 году местные фирмы, создающие их, привлекли 183 миллиона долларов в свои разработки. Это следует из отчета компании «Start-UP national central», который был представлен в преддверии открытия израильской технологической конференции Mixiii Biomed 2017. В нашей стране она будет [...]